Clinical Trials Browser

Suspended × OTHER × Ipilimumab × Clear all

NCT05928806 2026-02-11

ARCITECT

Phase 2 Suspended

Advanced Renal Cell Carcinoma

NCT06049576 2025-12-17

Nivolumab and Ipilimumab With and Without Camu Camu for the Treatment of Patients With Metastatic Renal Cell Carcinoma

Phase 1 Suspended

Carcinoma, Renal Cell